Avadel Pharma (AVDL) Reports Q4 Loss of $0.46/Share

Avadel Pharma (NASDAQ: AVDL) reported Q4 EPS of ($0.46), versus ($0.25) reported last year. Revenue for the quarter came in at $20.9 million, versus $34.75 million reported last year.

For earnings history and earnings-related data on Avadel Pharma (AVDL) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• Broadcom results, guidance beat on soaring AI chip sales; stock slips after hours
• Palo Alto Networks stock dips despite quarterly beat, raised profit outlook